MiMedx Group's average Accounts Receivable for the
three
months ended in Dec. 2023 was $51.4 Mil. MiMedx Group's Revenue for the
three
months ended in Dec. 2023 was $86.8 Mil.
Hence, MiMedx Group's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 54.06.
The historical rank and industry rank for MiMedx Group's Days Sales Outstanding or its related term are showing as below:
MDXG'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 39.43 Med: 57.14 Max: 99.52
Current: 54.41
During the past 13 years, MiMedx Group's highest Days Sales Outstanding was 99.52. The lowest was 39.43. And the median was 57.14.
MDXG's Days Sales Outstanding is ranked better than 64.08% of 888
companies
in the Biotechnology industry
Industry Median: 72.105
vs MDXG: 54.41
MiMedx Group's Days Sales Outstanding
increased
from Dec. 2022 (51.48) to Dec. 2023 (54.06).
MiMedx Group Days Sales Outstanding Historical Data
The historical data trend for MiMedx Group's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, MiMedx Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MiMedx Group Days Sales Outstanding Distribution
For the Biotechnology industry and Healthcare sector, MiMedx Group's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where MiMedx Group's Days Sales Outstanding falls into.
MiMedx Group Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MiMedx Group (NAS:MDXG) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
MiMedx Group Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of MiMedx Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, MiMedx sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MDXG has been successfully added to your 